Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States

Stepan, A. F., Walker, D. P., Bauman, J. N., Price, D. A., Baillie, T. A., Kalgutkar, A. S. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 711 · see citing works

Cutaneous Drug Reactions

Svensson, C. K., Cowen, E. W., & Gaspari, A. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01501-1 · Cited by 274 · see citing works

Immune pathomechanism of drug hypersensitivity reactions

Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 186 · see citing works

Deleterious Effects of Reactive Metabolites

Attia, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.4.13246 · Cited by 175 · see citing works

The danger hypothesis—potential role in idiosyncratic drug reactions

Pirmohamed, M., Naisbitt, D. J., Gordon, F., & Park, B. K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00255-x · Cited by 164 · see citing works

Mechanisms of NSAID-Induced Hepatotoxicity

Boelsterli, U. A. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00003 · Cited by 164 · see citing works

A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug Reactions

Reilly, T. P., Lash, L. H., Doll, M. A., Hein, D. W., Woster, P. M., & Svensson, C. K. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00985.x · Cited by 150 · see citing works

Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation

Naisbitt, D. J., Farrell, J., Gordon, S. F., Maggs, J. L., Burkhart, C., Pichler, W. J., Pirmohamed, M., & Park, B. K. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.628 · Cited by 141 · see citing works

Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity

Naisbitt, D. J., Hough, S. J., Gill, H., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702453 · Cited by 134 · see citing works

Idiosyncratic toxicity associated with potentiated sulfonamides in the dog

Trepanier, L. A. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00576.x · Cited by 134 · see citing works

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation <i>in vivo</i>

Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., & Park, B. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704074 · Cited by 133 · see citing works

The Biochemistry of Drug Metabolism – An Introduction

Testa, B., & Krämer, S. D. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890199 · Cited by 132 · see citing works

Advances in molecular toxicology–towards understanding idiosyncratic drug toxicity

Park, B. K., Kitteringham, N. R., Powell, H., & Pirmohamed, M. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00303-6 · Cited by 129 · see citing works

Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling

Sanderson, J. P., Naisbitt, D. J., Farrell, J., Ashby, C. A., TUCKER, M., Rieder, M. J., Pirmohamed, M., Clarke, S. E., & Park, B. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5533 · Cited by 123 · see citing works

Metabolic activation in drug allergies

Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., & Pirmohamed, M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00397-8 · Cited by 122 · see citing works

Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?

Knowles, S. R., Shapiro, L. E., & Shear, N. H. (2001) · Drug Safety · doi:10.2165/00002018-200124040-00001 · Cited by 117 · see citing works

In vitroanalysis of metabolic predisposition to drug hypersensitivity reactions

Riley, R. J., & Leeder, J. S. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03463.x · Cited by 114 · see citing works

Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity?

Kalgutkar, A. S. S., & Didiuk, M. T. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900055 · Cited by 103 · see citing works

Allergic adverse reactions to sulfonamides

Choquet‐Kastylevsky, G., Vial, T., & Descotes, J. (2002) · Current Allergy and Asthma Reports · doi:10.1007/s11882-002-0033-y · Cited by 102 · see citing works

Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity

Park, B. K., Laverty, H., Srivastava, A., Antoine, D. J., Naisbitt, D. J., & Williams, D. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.011 · Cited by 102 · see citing works

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

Kongpan, T., Mahasirimongkol, S., Konyoung, P., Kanjanawart, S., Chumworathayi, P., Wichukchinda, N., Kidkeukarun, R., Preechakul, S., Khunarkornsiri, U., Bamrungram, W., et al. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000153 · Cited by 95 · see citing works

Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells

Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95 · see citing works

Comparison of the In Vitro Cytotoxicity of Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone

Reilly, T. P., Bellevue, F. H., Woster, P. M., & Svensson, C. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00547-9 · Cited by 90 · see citing works

Drug-induced bile duct injury

Visentin, M., Lenggenhager, D. M., Gai, Z., & Kullak-Ublick, G. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.033 · Cited by 88 · see citing works

The Generation, Detection, and Effects of Reactive Drug Metabolites

Stachulski, A. V., Baillie, T. A., Park, B. K., Obach, R. S., Dalvie, D., Williams, D. P., Srivastava, A., Regan, S., Antoine, D. J., Goldring, C. E., et al. (2012) · Medicinal Research Reviews · doi:10.1002/med.21273 · Cited by 88 · see citing works

Sulfonamide Hypersensitivity: Fact and Fiction

Khan, D. A., Knowles, S. R., & Shear, N. H. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.034 · Cited by 87 · see citing works

The Role of Active Metabolites in Drug Toxicity

Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (1994) · Drug Safety · doi:10.2165/00002018-199411020-00006 · Cited by 86 · see citing works

Multiple Adduction Reactions of Nitroso Sulfamethoxazole with Cysteinyl Residues of Peptides and Proteins: Implications for Hapten Formation

Callan, H. E., Jenkins, R. E., Maggs, J. L., Lavergne, S. N., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900034r · Cited by 84 · see citing works

N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism

Spielberg, S. P. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353477 · Cited by 81 · see citing works

Metabolism of sulfamethoxazole in Arabidopsis thaliana cells and cucumber seedlings

Dudley, S., Sun, C., Jiang, J., & Gan, J. J. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.07.094 · Cited by 76 · see citing works

Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology

Erve, J. C. L. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.923 · Cited by 74 · see citing works

Characterization of Sulfamethoxazole and Sulfamethoxazole Metabolite-Specific T-Cell Responses in Animals and Humans

Farrell, J., Naisbitt, D. J., Drummond, N. S., Depta, J. P. H., Vilar, F. J., Pirmohamed, M., & Park, B. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050112 · Cited by 74 · see citing works

Mechanism of bioactivation and covalent binding of 2,4,6-trinitrotoluene

Leung, K., Yao, M., Stearns, R. A., & Chiu, S. L. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03606-9 · Cited by 73 · see citing works

Drug metabolism, danger signals, and drug-induced hypersensitivity

Gruchalla, R. S. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118509 · Cited by 73 · see citing works

Reactive metabolites and their role in drug reactions

Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00007 · Cited by 69 · see citing works

Haptenation of Sulfonamide Reactive Metabolites to Cellular Proteins

Manchanda, T., Hess, D. A., Dale, L., Ferguson, S. S. G., & Rieder, M. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1011 · Cited by 69 · see citing works

The Relationship Between the Disposition and Immunogenicity of Sulfamethoxazole in the Rat

Gill, H., Hough, S. J., Naisbitt, D. J., Maggs, J. L., Kitteringham, N. R., Pirmohamed, M., & Park, B. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36867-3 · Cited by 69 · see citing works

Synthesis and reactions of nitroso sulphamethoxazole with biological nucleophiles: Implications for immune mediated toxicity

Naisbitt, D. J., O’Neill, P. M., Pirmohamed, M., & Park, B. K. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00260-0 · Cited by 67 · see citing works

Pharmacogenetics of Adverse Drug Reactions

Osanlou, O., Pirmohamed, M., & Daly, A. K. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.002 · Cited by 67 · see citing works

Drug Antigenicity, Immunogenicity, and Costimulatory Signaling: Evidence for Formation of a Functional Antigen through Immune Cell Metabolism

Elsheikh, A., Lavergne, S. N., Castrejón-Flores, J. L., Farrell, J., Wang, H., Sathish, J. G., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000889 · Cited by 62 · see citing works

Role of bioactivation in drug-induced hypersensitivity reactions

Sanderson, J. P., Naisbitt, D. J., & Park, B. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080107 · Cited by 61 · see citing works

Toxicophores: groups and metabolic routes associated with increased safety risk.

Williams, D. P., & Naisbitt, D. J. (2002) · PubMed · Cited by 62 · see citing works

Slow acetylator phenotype and genotype in HIV‐positive patients with sulphamethoxazole hypersensitivity

Alfirevic, A., Stalford, A. C., Vilar, F. J., Wilkins, E., Park, B. K., & Pirmohamed, M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01754.x · Cited by 62 · see citing works

Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes

Vyas, P. M., Roychowdhury, S., Woster, P. M., & Svensson, C. K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.023 · Cited by 61 · see citing works

Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions

Kalish, R. S., LaPorte, A., Wood, J. A., & Johnson, K. L. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90202-x · Cited by 60 · see citing works

The importance of hapten–protein complex formation in the development of drug allergy

Faulkner, L., Meng, X., Park, B. K., & Naisbitt, D. J. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000078 · Cited by 57 · see citing works

Methemoglobin Formation by Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone: Implications for Differences in Adverse Drug Reactions

Reilly, T., Woster, P. M., & Svensson, C. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38046-2 · Cited by 57 · see citing works

Immediate‐type hypersensitivity drug reactions

Stone, S. F., Phillips, E. J., Wiese, M. D., Heddle, R. J., & Brown, S. G. A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12297 · Cited by 53 · see citing works

Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes

Roychowdhury, S., Vyas, P. M., Reilly, T. P., Gaspari, A. A., & Svensson, C. K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086009 · Cited by 54 · see citing works

“Danger” Conditions Increase Sulfamethoxazole-Protein Adduct Formation in Human Antigen-Presenting Cells

Lavergne, S. N., Wang, H., Callan, H., Park, B. K., & Naisbitt, D. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155374 · Cited by 51 · see citing works

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

van der Ven, A., Mantel, M., Vree, T. B., Koopmans, P., & van der Meer, J. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04339.x · Cited by 52 · see citing works

Reactions of oxidatively activated arylamines with thiols: reaction mechanisms and biologic implications. An overview.

Eyer, P. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s6123 · Cited by 51 · see citing works

Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis

Elsheikh, A., Castrejón-Flores, J. L., Lavergne, S. N., Whitaker, P., Monshi, M. M., Callan, H., El-Ghaiesh, S. H., Farrell, J., Pichler, W. J., Peckham, D. G., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1119 · Cited by 46 · see citing works

Specific polyclonal-based immunoassays for sulfathiazole

Pastor-Navarro, N., Garc�a-Bover, C., Maquieira, �., & Puchades, R. (2004) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-004-2683-1 · Cited by 47 · see citing works

Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins

Cribb, A. E., Pohl, L. R., Spielberg, S. P., & Leeder, J. S. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36874-0 · Cited by 46 · see citing works

Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole

van der Ven, A., Vree, T., van Ewijk‐Beneken Kolmer, E., Koopmans, P., & van der Meer, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05721.x · Cited by 45 · see citing works

Safety of Celecoxib in Individuals Allergic to Sulfonamide

Shapiro, L. E., Knowles, S. R., Weber, E., Neuman, M. G., & Shear, N. H. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00004 · Cited by 45 · see citing works

Mechanisms of drug reactions: The metabolic track

Shapiro, L. E., & Shear, N. H. (1996) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(96)80034-4 · Cited by 45 · see citing works

Idiosyncratic Drug Hepatotoxicity Revisited: New Insights from Mechanistic Toxicology

Boelsterli, U. A. (2003) · Toxicology Mechanisms and Methods · doi:10.1080/15376510309824 · Cited by 44 · see citing works

Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients

Wang, D., Curtis, A., Papp, A. C., Koletar, S. L., & Para, M. F. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-32 · Cited by 42 · see citing works

Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells

Summan, M., & Cribb, A. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00060-1 · Cited by 42 · see citing works

Time-course of toxicity of reactive sulfonamide metabolites

Rieder, M. J., Krause, R. S., & Bird, I. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02900-f · Cited by 42 · see citing works

Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS

Wolkenstein, P., Loriot, M., Aractingi, S., Cabelguenne, A., Beaune, P. H., & Chosidow, O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00007 · Cited by 41 · see citing works

Monitoring Adverse Drug Reactions to Sulfonamide Antibiotics in Human Immunodeficiency Virus–Infected Individuals

Neuman, M. G., Malkiewicz, I. M., Phillips, E. J., Rachlis, A., Ong, D., Yeung, E., & Shear, N. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200212000-00008 · Cited by 40 · see citing works

Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers*

Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattery, J. T. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80011-7 · Cited by 40 · see citing works

Sulfonamide Drug Allergy

Dorn, J. M., Alpern, M. L., McNulty, C. M. G., & Volcheck, G. W. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0791-9 · Cited by 36 · see citing works

Combination of GSH Trapping and Time-Dependent Inhibition Assays as a Predictive Method of Drugs Generating Highly Reactive Metabolites

Nakayama, S., Takakusa, H., Watanabe, A., Miyaji, Y., Suzuki, W., Sugiyama, D., Shiosakai, K., Honda, K., Okudaira, N., Izumi, T., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039180 · Cited by 36 · see citing works

Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo

Cheng, L., Stewart, B. J. R., You, Q., Petersen, D. R., Ware, J. A., Piccotti, J. R., Kawabata, T. T., & Ju, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043273 · Cited by 34 · see citing works

Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus

Soejima, M., Sugiura, T., Kawaguchi, Y., Kawamoto, M., Katsumata, Y., Takagi, K., Nakajima, A., Mitamura, T., Mimori, A., Hara, M., et al. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2134 · Cited by 34 · see citing works

Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso

Lavergne, S. N., Kurian, J. R., Bajad, S. U., Maki, J. E., Yoder, A. R., Guzinski, M. V., Graziano, F. M., & Trepanier, L. A. (2006) · Toxicology · doi:10.1016/j.tox.2006.01.018 · Cited by 32 · see citing works

Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?

Kalgutkar, A. S. S., Fate, G. D., Didiuk, M. T., & Bauman, J. N. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.4.515 · Cited by 32 · see citing works

Recognition of Local Anesthetics by αβ+ T Cells

Zanni, M. P., von Greyerz, S., Hari, Y., Schnyder, B., & Pichler, W. J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00484.x · Cited by 32 · see citing works

Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)

Ott, G., Plitzko, B., Krischkowski, C., Reichmann, D., Bittner, F., Mendel, R. R., Kunze, T., Clement, B., & Havemeyer, A. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500174u · Cited by 31 · see citing works

Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides

Elzagallaai, A. A., Sultan, E. A., Bend, J. R., Abuzgaia, A. M., Loubani, E., & Rieder, M. J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1535 · Cited by 31 · see citing works

Plasma Ascorbate Deficiency Is Associated With Impaired Reduction of Sulfamethoxazole-Nitroso in HIV Infection

Trepanier, L. A., Yoder, A. R., Bajad, S. U., Beckwith, M. D., Bellehumeur, J. L., & Graziano, F. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00007 · Cited by 31 · see citing works

Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection

Lin, D., TUCKER, M., & Rieder, M. J. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g525 · Cited by 31 · see citing works

Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides

Neuman, M. G., Shear, N. H., Malkiewicz, I. M., Taeri, M., Shapiro, L. E., Krivoy, N., Haber, J. A., Gómez, M., Fish, J. S., Cartotto, R. C., et al. (2007) · Translational research · doi:10.1016/j.trsl.2006.12.001 · Cited by 31 · see citing works

Metabolic and Chemical Origins of Cross-Reactive Immunological Reactions to Arylamine Benzenesulfonamides: T-Cell Responses to Hydroxylamine and Nitroso Derivatives

Castrejón-Flores, J. L., Lavergne, S. N., El-Sheikh, A., Farrell, J., Maggs, J. L., Sabbani, S., O’Neill, P. M., Park, B. K., & Naisbitt, D. J. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900329b · Cited by 29 · see citing works

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase

Ogese, M. O., Jenkins, R. E., Maggs, J. L., Meng, X., Whitaker, P., Peckham, D. G., Faulkner, L., Park, B. K., & Naisbitt, D. J. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500458k · Cited by 29 · see citing works

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity

Sacco, J., Abouraya, M., Motsinger‐Reif, A. A., Yale, S. H., McCarty, C. A., & Trepanier, L. A. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328357a735 · Cited by 27 · see citing works

Toxicogenetics in drug development

Park, B. K., & Pirmohamed, M. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00280-6 · Cited by 27 · see citing works

Handling reactive metabolite positives in drug discovery: What has retrospective structure–toxicity analyses taught us?

Kalgutkar, A. S. S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.003 · Cited by 25 · see citing works

Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver

Veggi, L. M., Pretto, L., Ochoa, E. J., Catania, V. A., Luquita, M. G., Taborda, D. R., Pozzi, E. J. S., Ikushiro, S., Coleman, M. D., Roma, M. G., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.016 · Cited by 25 · see citing works

N-acetyltransferase: the practical consequences of polymorphic activity in man

Mitchell, S. C. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1618511 · Cited by 24 · see citing works

Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients

Kagaya, H., Miura, M., Niioka, T., Saito, M., Numakura, K., Habuchi, T., & Satoh, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05037-11 · Cited by 23 · see citing works

Aerobic 2- and 4-nitroreduction of CB 1954 by human liver

Tang, M. H. Y., Helsby, N. A., Wilson, W. R., & Tingle, M. D. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.021 · Cited by 23 · see citing works

Direct ELlSAs for Sulfathiazole in Milk and Honey with Special Emphasis on Enzyme Conjugate Preparation

Thomson, C. A., & Sporns, P. (1995) · Journal of Food Science · doi:10.1111/j.1365-2621.1995.tb05683.x · Cited by 22 · see citing works

Novel Clinical Biomarkers for Drug-Induced Liver Injury

Chen, Y., Guan, S., Guan, Y., Tang, S., Zhou, Y., Wang, X., Bi, H., & Huang, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000732 · Cited by 21 · see citing works

Adverse Drug Reactions: Mechanisms and Assessment

Ring, J., & Brockow, K. (2002) · European Surgical Research · doi:10.1159/000048905 · Cited by 21 · see citing works

Immunological principles of T-cell-mediated adverse drug reactions in skin

Naisbitt, D. J., Pirmohamed, M., & Park, B. K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.109 · Cited by 19 · see citing works

Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites

Choquet‐Kastylevsky, G., Santolaria, N., Tédone, R., Aujoulat, M., & Descotes, J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(00)00313-1 · Cited by 19 · see citing works

Pharmacokinetics of sulfamethoxazole with its hydroxy metabolites and N4-acetyl-, N1-glucuronide conjugates in healthy human volunteers

Vree, T. B., van der Ven, A. J. A. M., Koopmans, P. P., van Ewijk-Beneken Kolmer, E. W. J., & Verwey-van Wissen, C. P. W. G. M. (1995) · Clinical Drug Investigation · doi:10.2165/00044011-199509010-00008 · Cited by 18 · see citing works

Metabolic Disposition and Elimination of Tritum-Labeled Sulfamethoxazole in Pigs, Chickens and Rats

Guo, J., Sun, Y., Zhao, Y., Huang, L., Peng, D., Hao, H., Tao, Y., Chen, D., Cheng, G., Wang, X., et al. (2022) · Metabolites · doi:10.3390/metabo13010057 · Cited by 18 · see citing works

Diagnosis of allergic reactions to sulfonamides

Gruchalla, R. S. (1999) · Allergy · doi:10.1111/j.1398-9995.1999.tb04745.x · Cited by 18 · see citing works

Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?

Sullivan, A. K., Gibson, A., Park, B. K., & Naisbitt, D. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.992780 · Cited by 17 · see citing works

IgE and Drug Allergy: Antibody Recognition of ‘Small’ Molecules of Widely Varying Structures and Activities

Baldo, B. A. (2014) · Antibodies · doi:10.3390/antib3010056 · Cited by 16 · see citing works

Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4 T-cells

HOPKINS, J., Naisbitt, D. J., HUMPHREYS, N., Dearman, R. J., Kimber, I., & PARK, B. (2004) · Toxicology · doi:10.1016/j.tox.2004.08.010 · Cited by 16 · see citing works

Immunochemical Approaches to the Detection of Sulfathiazole in Animal Tissues

Lee, N. A., Holtzapple, C. K., Muldoon, M. T., Deshpande, S. S., & Stanker, L. H. (2001) · Food and Agricultural Immunology · doi:10.1080/09540100051074149 · Cited by 15 · see citing works

Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions

Nakkam, N., Saksit, N., Konyoung, P., Amornpinyo, W., Khunarkornsiri, U., Purimart, D., Pattanacheewapull, O., Naewla, T., Wattanachai, P., Khaeso, K., et al. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100480 · Cited by 14 · see citing works

Inhibition of cytokine production and interference in IL‐2 receptor‐mediated Jak‐Stat signaling by the hydroxylamine metabolite of sulfamethoxazole

Hess, D. A., O'Leary, E. F., Lee, J. T., Almawi, W. Y., Madrenas, J., & Rieder, M. J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0583fje · Cited by 14 · see citing works

Time-course of toxicity of reactive sulfonamide metabolites

Rieder, M. J., Krause, R. S., & Bird, I. A. (1995) · Toxicology · doi:10.1016/0300-483x(94)02900-f · Cited by 42 · see citing works

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

Rieder, M. J., Uetrecht, J., Shear, N. H., & Spielberg, S. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24502-5 · Cited by 148 · see citing works

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine

Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65 · see citing works

Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells

Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95 · see citing works

SULFAMETHOXAZOLE HYPERSENSITIVITY REACTIONS ARE MEDIATED BY A HYDROXYLAMINE METABOLITE

Rieder, M. J., Cannon, M., Uetrecht, J., & Soielbera, S. P. (1987) · Pediatric Research · doi:10.1203/00006450-198704010-00442